Avanir Pharmaceuticals Reports EPS of $(0.12) vs. $(0.14) Estimate; Revenues $1.4M vs. $2.75M Estimate

by Benzinga Staff
May 9, 2011 4:02 PM | 6 seconds read |
Avanir Pharmaceuticals AVNR Reports EPS of $(0.12) vs. $(0.14) Estimate; Revenues $1.4M vs. $2.75M Estimate
Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Comments
Posted In: EarningsNewsHealth CarePharmaceuticals
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!